FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.8.7  |  FHIR Version n/a  User: [n/a]

38112003: 1 (qualifier value)

    Status: retired, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jan 2023. Module: SNOMED CT core

    Descriptions:

    Id Description Lang Type Status Case? Module
    64719019 One en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core
    3442104013 1 (qualifier value) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT core
    3442105014 1 en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core

    0 descendants.

    Expanded Value Set

    Outbound Relationships Type Target Active Characteristic Refinability Group Values
    1 Is a General adjectival modifier false Inferred relationship Some
    1 Is a Number false Inferred relationship Some
    Inbound Relationships Type Active Source Characteristic Refinability Group
    Tiludronic acid (as tiludronate disodium) 200 mg oral tablet Has presentation strength denominator value False 1 Inferred relationship Some 1
    Product containing precisely tamoxifen (as tamoxifen citrate) 40 milligram/1 each conventional release oral tablet (clinical drug) Has presentation strength denominator value False 1 Inferred relationship Some 1
    Product containing precisely tamoxifen (as tamoxifen citrate) 40 milligram/1 each conventional release oral tablet (clinical drug) Count of base of active ingredient False 1 Inferred relationship Some
    Product containing precisely nelfinavir (as nelfinavir mesilate) 625 milligram/1 each conventional release oral tablet (clinical drug) Has presentation strength denominator value False 1 Inferred relationship Some 1
    Product containing precisely nelfinavir (as nelfinavir mesilate) 625 milligram/1 each conventional release oral tablet (clinical drug) Count of base of active ingredient False 1 Inferred relationship Some
    Meptazinol (as meptazinol hydrochloride) 200 mg oral tablet Count of base of active ingredient False 1 Inferred relationship Some
    Meptazinol (as meptazinol hydrochloride) 200 mg oral tablet Has presentation strength denominator value False 1 Inferred relationship Some 1
    Product containing precisely trifluoperazine (as trifluoperazine hydrochloride) 5 milligram/1 each conventional release oral tablet (clinical drug) Count of base of active ingredient False 1 Inferred relationship Some
    Product containing precisely trifluoperazine (as trifluoperazine hydrochloride) 5 milligram/1 each conventional release oral tablet (clinical drug) Has presentation strength denominator value False 1 Inferred relationship Some 1
    Product containing precisely nebivolol (as nebivolol hydrochloride) 10 milligram/1 each conventional release oral tablet (clinical drug) Count of base of active ingredient False 1 Inferred relationship Some
    Product containing precisely nebivolol (as nebivolol hydrochloride) 10 milligram/1 each conventional release oral tablet (clinical drug) Has presentation strength denominator value False 1 Inferred relationship Some 1
    Venlafaxine (as venlafaxine hydrochloride) 75 mg oral tablet Has presentation strength denominator value False 1 Inferred relationship Some 1
    Venlafaxine (as venlafaxine hydrochloride) 75 mg oral tablet Count of base of active ingredient False 1 Inferred relationship Some
    Product containing precisely varenicline (as varenicline tartrate) 1 milligram/1 each conventional release oral tablet (clinical drug) Count of base of active ingredient False 1 Inferred relationship Some
    Product containing precisely varenicline (as varenicline tartrate) 1 milligram/1 each conventional release oral tablet (clinical drug) Has presentation strength numerator value False 1 Inferred relationship Some 1
    Product containing precisely varenicline (as varenicline tartrate) 1 milligram/1 each conventional release oral tablet (clinical drug) Has presentation strength denominator value False 1 Inferred relationship Some 1
    Product containing precisely nortriptyline (as nortriptyline hydrochloride) 10 milligram/1 each conventional release oral tablet (clinical drug) Count of base of active ingredient False 1 Inferred relationship Some
    Product containing precisely nortriptyline (as nortriptyline hydrochloride) 10 milligram/1 each conventional release oral tablet (clinical drug) Has presentation strength denominator value False 1 Inferred relationship Some 1
    Product containing precisely cilazapril (as cilazapril monohydrate) 500 microgram/1 each conventional release oral tablet (clinical drug) Has presentation strength denominator value False 1 Inferred relationship Some 1
    Product containing precisely cilazapril (as cilazapril monohydrate) 500 microgram/1 each conventional release oral tablet (clinical drug) Count of base of active ingredient False 1 Inferred relationship Some
    Product containing precisely ruxolitinib (as ruxolitinib phosphate) 5 milligram/1 each conventional release oral tablet (clinical drug) Has presentation strength denominator value False 1 Inferred relationship Some 1
    Product containing precisely ruxolitinib (as ruxolitinib phosphate) 5 milligram/1 each conventional release oral tablet (clinical drug) Count of base of active ingredient False 1 Inferred relationship Some
    Product containing precisely amoxicillin (as amoxicillin trihydrate) 875 milligram and clavulanic acid (as clavulanate potassium) 125 milligram/1 each conventional release oral tablet (clinical drug) Has presentation strength denominator value False 1 Inferred relationship Some 1
    Product containing precisely amoxicillin (as amoxicillin trihydrate) 875 milligram and clavulanic acid (as clavulanate potassium) 125 milligram/1 each conventional release oral tablet (clinical drug) Has presentation strength denominator value False 1 Inferred relationship Some 2
    Product containing precisely tiagabine (as tiagabine hydrochloride monohydrate) 5 milligram/1 each conventional release oral tablet (clinical drug) Count of base of active ingredient False 1 Inferred relationship Some
    Product containing precisely tiagabine (as tiagabine hydrochloride monohydrate) 5 milligram/1 each conventional release oral tablet (clinical drug) Has presentation strength denominator value False 1 Inferred relationship Some 1
    Product containing precisely imatinib (as imatinib mesilate) 400 milligram/1 each conventional release oral tablet (clinical drug) Has presentation strength denominator value False 1 Inferred relationship Some 1
    Product containing precisely imatinib (as imatinib mesilate) 400 milligram/1 each conventional release oral tablet (clinical drug) Count of base of active ingredient False 1 Inferred relationship Some
    Levothyroxine sodium anhydrous 75 microgram oral tablet Count of base of active ingredient False 1 Inferred relationship Some
    Levothyroxine sodium anhydrous 75 microgram oral tablet Has presentation strength denominator value False 1 Inferred relationship Some 1
    Product containing precisely conjugated estrogen 625 microgram and medroxyprogesterone acetate 5 milligram/1 each conventional release oral tablet (clinical drug) Has presentation strength denominator value False 1 Inferred relationship Some 2
    Product containing precisely conjugated estrogen 625 microgram and medroxyprogesterone acetate 5 milligram/1 each conventional release oral tablet (clinical drug) Has presentation strength denominator value False 1 Inferred relationship Some 1
    Levothyroxine sodium anhydrous 100 microgram oral tablet Has presentation strength denominator value False 1 Inferred relationship Some 1
    Levothyroxine sodium anhydrous 100 microgram oral tablet Count of base of active ingredient False 1 Inferred relationship Some
    Flucloxacillin (as flucloxacillin sodium) 500 mg oral capsule Has presentation strength denominator value False 1 Inferred relationship Some 1
    Flucloxacillin (as flucloxacillin sodium) 500 mg oral capsule Count of base of active ingredient False 1 Inferred relationship Some
    Lofepramine (as lofepramine hydrochloride) 70 mg oral tablet Count of base of active ingredient False 1 Inferred relationship Some
    Lofepramine (as lofepramine hydrochloride) 70 mg oral tablet Has presentation strength denominator value False 1 Inferred relationship Some 1
    Product containing only ravulizumab in parenteral dose form (medicinal product form) Count of base of active ingredient False 1 Inferred relationship Some
    Product containing only ravulizumab (medicinal product) Count of base of active ingredient False 1 Inferred relationship Some
    Product containing precisely carbidopa (as carbidopa monohydrate) 10 milligram and levodopa 100 milligram/1 each conventional release oral tablet (clinical drug) Has presentation strength denominator value False 1 Inferred relationship Some 1
    Product containing precisely carbidopa (as carbidopa monohydrate) 10 milligram and levodopa 100 milligram/1 each conventional release oral tablet (clinical drug) Has presentation strength denominator value False 1 Inferred relationship Some 2
    Quinagolide (as quinagolide hydrochloride) 75 microgram oral tablet Count of base of active ingredient False 1 Inferred relationship Some
    Quinagolide (as quinagolide hydrochloride) 75 microgram oral tablet Has presentation strength denominator value False 1 Inferred relationship Some 1
    Product containing precisely levofloxacin (as levofloxacin hemihydrate) 250 milligram/1 each conventional release oral tablet (clinical drug) Count of base of active ingredient False 1 Inferred relationship Some
    Product containing precisely levofloxacin (as levofloxacin hemihydrate) 250 milligram/1 each conventional release oral tablet (clinical drug) Has presentation strength denominator value False 1 Inferred relationship Some 1
    Product containing precisely ibandronic acid (as ibandronate sodium monohydrate) 50 milligram/1 each conventional release oral tablet (clinical drug) Count of base of active ingredient False 1 Inferred relationship Some
    Product containing precisely ibandronic acid (as ibandronate sodium monohydrate) 50 milligram/1 each conventional release oral tablet (clinical drug) Has presentation strength denominator value False 1 Inferred relationship Some 1
    Salbutamol (as salbutamol sulfate) 4 mg oral tablet Has presentation strength denominator value False 1 Inferred relationship Some 1
    Salbutamol (as salbutamol sulfate) 4 mg oral tablet Count of base of active ingredient False 1 Inferred relationship Some
    Product containing precisely carbidopa (as carbidopa monohydrate) 12.5 milligram and levodopa 50 milligram/1 each conventional release oral tablet (clinical drug) Has presentation strength denominator value False 1 Inferred relationship Some 2
    Product containing precisely carbidopa (as carbidopa monohydrate) 12.5 milligram and levodopa 50 milligram/1 each conventional release oral tablet (clinical drug) Has presentation strength denominator value False 1 Inferred relationship Some 1
    Product containing precisely loxapine (as loxapine succinate) 10 milligram/1 each conventional release oral capsule (clinical drug) Has presentation strength denominator value False 1 Inferred relationship Some 1
    Product containing precisely loxapine (as loxapine succinate) 10 milligram/1 each conventional release oral capsule (clinical drug) Count of base of active ingredient False 1 Inferred relationship Some
    Product containing precisely ampicillin (as ampicillin trihydrate) 250 milligram and flucloxacillin (as flucloxacillin sodium) 250 milligram/1 each conventional release oral capsule (clinical drug) Has presentation strength denominator value False 1 Inferred relationship Some 1
    Product containing precisely ampicillin (as ampicillin trihydrate) 250 milligram and flucloxacillin (as flucloxacillin sodium) 250 milligram/1 each conventional release oral capsule (clinical drug) Has presentation strength denominator value False 1 Inferred relationship Some 2
    Product containing precisely imatinib (as imatinib mesilate) 100 milligram/1 each conventional release oral tablet (clinical drug) Count of base of active ingredient False 1 Inferred relationship Some
    Product containing precisely imatinib (as imatinib mesilate) 100 milligram/1 each conventional release oral tablet (clinical drug) Has presentation strength denominator value False 1 Inferred relationship Some 1
    Levothyroxine sodium anhydrous 25 microgram oral capsule Has presentation strength denominator value False 1 Inferred relationship Some 1
    Levothyroxine sodium anhydrous 25 microgram oral capsule Count of base of active ingredient False 1 Inferred relationship Some
    Pergolide (as pergolide mesilate) 250 microgram oral tablet Has presentation strength denominator value False 1 Inferred relationship Some 1
    Pergolide (as pergolide mesilate) 250 microgram oral tablet Count of base of active ingredient False 1 Inferred relationship Some
    Product containing precisely paroxetine (as paroxetine hydrochloride) 10 milligram/1 each conventional release oral tablet (clinical drug) Count of base of active ingredient False 1 Inferred relationship Some
    Product containing precisely paroxetine (as paroxetine hydrochloride) 10 milligram/1 each conventional release oral tablet (clinical drug) Has presentation strength denominator value False 1 Inferred relationship Some 1
    Product containing precisely cisapride (as cisapride monohydrate) 10 milligram/1 each conventional release oral tablet (clinical drug) Count of base of active ingredient False 1 Inferred relationship Some
    Product containing precisely cisapride (as cisapride monohydrate) 10 milligram/1 each conventional release oral tablet (clinical drug) Has presentation strength denominator value False 1 Inferred relationship Some 1
    Product containing precisely fluphenazine hydrochloride 500 microgram and nortriptyline (as nortriptyline hydrochloride) 10 milligram/1 each conventional release oral tablet (clinical drug) Has presentation strength denominator value False 1 Inferred relationship Some 2
    Product containing precisely fluphenazine hydrochloride 500 microgram and nortriptyline (as nortriptyline hydrochloride) 10 milligram/1 each conventional release oral tablet (clinical drug) Has presentation strength denominator value False 1 Inferred relationship Some 1
    Product containing precisely quetiapine (as quetiapine fumarate) 150 milligram/1 each conventional release oral tablet (clinical drug) Count of base of active ingredient False 1 Inferred relationship Some
    Product containing precisely quetiapine (as quetiapine fumarate) 150 milligram/1 each conventional release oral tablet (clinical drug) Has presentation strength denominator value False 1 Inferred relationship Some 1
    Product containing precisely carbidopa (as carbidopa monohydrate) 25 milligram and levodopa 100 milligram/1 each conventional release oral tablet (clinical drug) Has presentation strength denominator value False 1 Inferred relationship Some 1
    Product containing precisely carbidopa (as carbidopa monohydrate) 25 milligram and levodopa 100 milligram/1 each conventional release oral tablet (clinical drug) Has presentation strength denominator value False 1 Inferred relationship Some 2
    Reboxetine (as reboxetine mesilate) 4 mg oral tablet Has presentation strength denominator value False 1 Inferred relationship Some 1
    Reboxetine (as reboxetine mesilate) 4 mg oral tablet Count of base of active ingredient False 1 Inferred relationship Some
    Product containing precisely loxapine (as loxapine succinate) 25 milligram/1 each conventional release oral capsule (clinical drug) Has presentation strength denominator value False 1 Inferred relationship Some 1
    Product containing precisely loxapine (as loxapine succinate) 25 milligram/1 each conventional release oral capsule (clinical drug) Count of base of active ingredient False 1 Inferred relationship Some
    Product containing precisely pergolide (as pergolide mesilate) 1 milligram/1 each conventional release oral tablet (clinical drug) Count of base of active ingredient False 1 Inferred relationship Some
    Product containing precisely pergolide (as pergolide mesilate) 1 milligram/1 each conventional release oral tablet (clinical drug) Has presentation strength denominator value False 1 Inferred relationship Some 1
    Product containing precisely pergolide (as pergolide mesilate) 1 milligram/1 each conventional release oral tablet (clinical drug) Has presentation strength numerator value False 1 Inferred relationship Some 1
    Product containing precisely levothyroxine sodium anhydrous 25 microgram/1 each conventional release oral tablet (clinical drug) Has presentation strength denominator value False 1 Inferred relationship Some 1
    Product containing precisely levothyroxine sodium anhydrous 25 microgram/1 each conventional release oral tablet (clinical drug) Count of base of active ingredient False 1 Inferred relationship Some
    Product containing precisely pergolide (as pergolide mesilate) 50 microgram/1 each conventional release oral tablet (clinical drug) Has presentation strength denominator value False 1 Inferred relationship Some 1
    Product containing precisely pergolide (as pergolide mesilate) 50 microgram/1 each conventional release oral tablet (clinical drug) Count of base of active ingredient False 1 Inferred relationship Some
    Product containing precisely disopyramide (as disopyramide phosphate) 100 milligram/1 each conventional release oral capsule (clinical drug) Has presentation strength denominator value False 1 Inferred relationship Some 1
    Product containing precisely disopyramide (as disopyramide phosphate) 100 milligram/1 each conventional release oral capsule (clinical drug) Count of base of active ingredient False 1 Inferred relationship Some
    Product containing precisely clopidogrel (as clopidogrel bisulfate) 75 milligram/1 each conventional release oral tablet (clinical drug) Count of base of active ingredient False 1 Inferred relationship Some
    Product containing precisely clopidogrel (as clopidogrel bisulfate) 75 milligram/1 each conventional release oral tablet (clinical drug) Has presentation strength denominator value False 1 Inferred relationship Some 1
    Product containing precisely fluphenazine hydrochloride 1.5 milligram and nortriptyline (as nortriptyline hydrochloride) 30 milligram/1 each conventional release oral tablet (clinical drug) Has presentation strength denominator value False 1 Inferred relationship Some 1
    Product containing precisely fluphenazine hydrochloride 1.5 milligram and nortriptyline (as nortriptyline hydrochloride) 30 milligram/1 each conventional release oral tablet (clinical drug) Has presentation strength denominator value False 1 Inferred relationship Some 2
    Product containing only tagraxofusp (medicinal product) Count of base of active ingredient False 1 Inferred relationship Some
    Product containing precisely carbidopa (as carbidopa monohydrate) 25 milligram and levodopa 250 milligram/1 each conventional release oral tablet (clinical drug) Has presentation strength denominator value False 1 Inferred relationship Some 1
    Product containing precisely carbidopa (as carbidopa monohydrate) 25 milligram and levodopa 250 milligram/1 each conventional release oral tablet (clinical drug) Has presentation strength denominator value False 1 Inferred relationship Some 2
    Ruxolitinib (as ruxolitinib phosphate) 10 mg oral tablet Has presentation strength denominator value False 1 Inferred relationship Some 1
    Ruxolitinib (as ruxolitinib phosphate) 10 mg oral tablet Count of base of active ingredient False 1 Inferred relationship Some
    Product containing precisely loxapine (as loxapine succinate) 50 milligram/1 each conventional release oral capsule (clinical drug) Has presentation strength denominator value False 1 Inferred relationship Some 1
    Product containing precisely loxapine (as loxapine succinate) 50 milligram/1 each conventional release oral capsule (clinical drug) Count of base of active ingredient False 1 Inferred relationship Some
    Product containing precisely darunavir (as darunavir ethanolate) 400 milligram/1 each conventional release oral tablet (clinical drug) Has presentation strength denominator value False 1 Inferred relationship Some 1
    Product containing precisely darunavir (as darunavir ethanolate) 400 milligram/1 each conventional release oral tablet (clinical drug) Count of base of active ingredient False 1 Inferred relationship Some
    Levothyroxine sodium anhydrous 38 microgram and liothyronine sodium 9 microgram oral tablet Has presentation strength denominator value False 1 Inferred relationship Some 1
    Levothyroxine sodium anhydrous 38 microgram and liothyronine sodium 9 microgram oral tablet Has presentation strength denominator value False 1 Inferred relationship Some 2
    Product containing precisely cilazapril (as cilazapril monohydrate) 2.5 milligram/1 each conventional release oral tablet (clinical drug) Has presentation strength denominator value False 1 Inferred relationship Some 1

    Start Previous Page 168 of 215 Next End

    Reference Sets

    Concept inactivation indicator reference set

    Back to Start